DE69206495T2 - Matrixtablette zur verlängerten Indapamidfreisetzung nach oraler Gabe. - Google Patents

Matrixtablette zur verlängerten Indapamidfreisetzung nach oraler Gabe.

Info

Publication number
DE69206495T2
DE69206495T2 DE69206495T DE69206495T DE69206495T2 DE 69206495 T2 DE69206495 T2 DE 69206495T2 DE 69206495 T DE69206495 T DE 69206495T DE 69206495 T DE69206495 T DE 69206495T DE 69206495 T2 DE69206495 T2 DE 69206495T2
Authority
DE
Germany
Prior art keywords
release
indapamide
oral administration
prolonged
matrix tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69206495T
Other languages
English (en)
Other versions
DE69206495D1 (de
Inventor
Alain Cuine
De Barochez Bruno Huet
David Guez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of DE69206495D1 publication Critical patent/DE69206495D1/de
Publication of DE69206495T2 publication Critical patent/DE69206495T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DE69206495T 1991-06-18 1992-06-18 Matrixtablette zur verlängerten Indapamidfreisetzung nach oraler Gabe. Expired - Lifetime DE69206495T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9107400A FR2677886B1 (fr) 1991-06-18 1991-06-18 Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.

Publications (2)

Publication Number Publication Date
DE69206495D1 DE69206495D1 (de) 1996-01-18
DE69206495T2 true DE69206495T2 (de) 1996-07-25

Family

ID=9413931

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69206495T Expired - Lifetime DE69206495T2 (de) 1991-06-18 1992-06-18 Matrixtablette zur verlängerten Indapamidfreisetzung nach oraler Gabe.

Country Status (14)

Country Link
US (1) US5334392A (de)
EP (1) EP0519820B1 (de)
JP (1) JP2638389B2 (de)
AT (1) ATE131050T1 (de)
AU (1) AU651894B2 (de)
CA (1) CA2071408C (de)
DE (1) DE69206495T2 (de)
DK (1) DK0519820T3 (de)
ES (1) ES2083119T3 (de)
FR (1) FR2677886B1 (de)
GR (1) GR3019017T3 (de)
HK (1) HK56397A (de)
IE (1) IE72192B1 (de)
ZA (1) ZA924482B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0800384T3 (da) * 1994-12-14 2001-04-17 Enbalt Trading Ltd Pharmaceutiske tabletformuleringer til direkte kompression
AU5609998A (en) * 1997-01-10 1998-08-03 Abbott Laboratories Tablet for the controlled release of active agents
FR2760190B1 (fr) * 1997-02-28 1999-04-09 Adir Composition pharmaceutique pour la liberation programmee de dexfenfluramine
FR2802424B1 (fr) * 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
PL193976B1 (pl) * 2002-07-01 2007-04-30 Pliva Krakow Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid
CA2519556C (en) 2003-04-21 2011-01-18 Benjamin Oshlack Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
CA2532714C (en) * 2003-08-04 2010-11-16 Kyorin Pharmaceutical Co., Ltd. Oral sustained-release tablet comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide
PL1691892T3 (pl) * 2003-12-09 2007-07-31 Euro Celtique Sa Odporna na fizyczne manipulowanie, współwytłaczana postać dawkowania zawierająca środek aktywny i środek przeciwdziałający oraz sposób wytwarzania tej postaci
US8883204B2 (en) 2003-12-09 2014-11-11 Purdue Pharma L.P. Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
DE102004005009A1 (de) * 2004-01-30 2005-09-01 Krka Tovarna Zdravil, D.D. Verzögert freisetzende pharmazeutische Zusammensetzung von Indapamid
JP2007530684A (ja) 2004-03-30 2007-11-01 ユーロ−セルティーク エス．エイ． 吸着剤と逆作用薬とを含有する不正使用防止投与剤型
FR2878748B1 (fr) * 2004-12-07 2007-03-09 Arrow Generiques Soc Par Actio Formule de comprimes permettant une liberation prolongee d'indapamide apres administration par voie orale et procede de preparation
DE102004062257A1 (de) 2004-12-23 2006-07-06 Merckle Gmbh Direkt verpresste Indapamid-Tabletten mit verzögerter Wirkstofffreisetzung
US20060182803A1 (en) * 2005-02-17 2006-08-17 Standard Chem. & Pharm. Co., Ltd. Oral sustained-release pharmaceutical composition of indapamide, production and use thereof
US20090264495A1 (en) * 2005-02-17 2009-10-22 Standard Chem. & Pharm. Co., Ltd. Oral sustained-release pharmaceutical composition of indapamide, production and use thereof
EA013472B1 (ru) * 2007-10-19 2010-04-30 Закрытое Акционерное Общество "Канонфарма Продакшн" Матричная таблетка с пролонгированным высвобождением индапамида, способ ее получения и способ лечения
EP2448406B1 (de) 2009-02-26 2016-04-20 Relmada Therapeutics, Inc. Oral einnehmbare pharmazeutische zusammensetzungen aus 3-hydroxy-n-methylmorphinan mit verzögerter freisetzung und verwendungsverfahren dafür
EP2380561A1 (de) 2010-04-21 2011-10-26 LEK Pharmaceuticals d.d. Zusammensetzung mit verlängerter Freisetzung enthaltend Indapamid
US8501009B2 (en) 2010-06-07 2013-08-06 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Fluid purification system
US20120040008A1 (en) 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120039999A1 (en) 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
AU2012318561B2 (en) 2011-10-07 2017-04-20 Outset Medical, Inc. Heat exchange fluid purification for dialysis system
EP2842711B1 (de) * 2013-08-26 2018-10-10 Airbus Operations GmbH Vorrichtung und Verfahren zur Herstellung einer Flugzeugkomponente aus Verbundmaterial
CN104324013B (zh) * 2014-10-30 2017-09-26 黄山中皇制药有限公司 吲达帕胺缓释剂的制备工艺
CN111150713B (zh) * 2018-11-07 2023-02-10 珠海润都制药股份有限公司 一种吲达帕胺胶囊及其制备方法
CN112370433A (zh) * 2020-12-07 2021-02-19 石家庄市华新药业有限责任公司 一种吲达帕胺缓释片及其制备方法
EP4295839A1 (de) 2022-06-20 2023-12-27 KRKA, d.d., Novo mesto Kombination aus valsartan und indapamid

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1203691A (en) * 1968-03-06 1970-09-03 Science Union & Cie New disubstituted n-amino indoline derivatives and process for preparing them
DE2520978C3 (de) * 1975-05-10 1981-02-19 Hoechst Ag, 6000 Frankfurt Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten
EP0153105B1 (de) * 1984-02-10 1992-09-09 Benzon Pharma A/S Dosierungsform eine Vielzahl mit einer Diffusionshülle überzogener Einheiten enthaltend
EP0178299A4 (de) * 1984-03-21 1987-04-28 Key Pharma Dosierungsform für naproxyn für dauerverabreichung im mund.
NL8600137A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die desgewenst met een diureticum gecombineerde 3-aminopropoxyindolen bevatten, alsmede werkwijzen voor het toepassen van deze preparaten.
GB2181053B (en) * 1985-10-01 1990-05-23 Sandoz Ltd Pharmaceutical formulations with controlled release of the active substance
FR2588188B1 (fr) * 1985-10-04 1988-01-08 Delalande Sa Comprime de sel(s) hydrosoluble(s) de cinepazide a liberation programmee et son procede de preparation
IT1187750B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di compresse,anche a rilascio prolungato,di iscsorbide-5-mononitrato stabilizzato e formulazioni cosi' ottenute
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4806359A (en) * 1987-04-22 1989-02-21 Mcneilab, Inc. Iburprofen sustained release matrix and process
US5004613A (en) * 1987-07-27 1991-04-02 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
FR2623714B1 (fr) * 1987-11-26 1990-04-20 Ethypharm Sa Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation

Also Published As

Publication number Publication date
JP2638389B2 (ja) 1997-08-06
CA2071408A1 (fr) 1992-12-19
ATE131050T1 (de) 1995-12-15
HK56397A (en) 1997-05-09
IE72192B1 (en) 1997-03-26
ES2083119T3 (es) 1996-04-01
EP0519820B1 (de) 1995-12-06
FR2677886B1 (fr) 1995-03-31
ZA924482B (en) 1993-08-18
US5334392A (en) 1994-08-02
CA2071408C (fr) 2001-06-12
JPH05186346A (ja) 1993-07-27
GR3019017T3 (en) 1996-05-31
AU651894B2 (en) 1994-08-04
DE69206495D1 (de) 1996-01-18
DK0519820T3 (da) 1996-04-22
AU1834392A (en) 1992-12-24
EP0519820A1 (de) 1992-12-23
IE921952A1 (en) 1992-12-30
FR2677886A1 (fr) 1992-12-24

Similar Documents

Publication Publication Date Title
ATE131050T1 (de) Matrixtablette zur verlängerten indapamidfreisetzung nach oraler gabe.
BR9205375A (pt) Composicao para a liberacao prolongada e controlada de uma substancia medicamentosa peptidica e processo para a sua preparacao
HUT47843A (en) Process for producing pharmaceutical with regulated active ingredient release
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
ES2097155T3 (es) Forma de dosificacion efervescente y metodo de administracion.
DE3886965D1 (de) Zubereitungen zur gesteuerten Wirkstofffreisetzung.
IT8820145A0 (it) Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
AU6667790A (en) Sustained release compositions for treating periodontal disease
ES2056955T3 (es) Formulacion oral de buspirona y sales de la misma.
DK68690D0 (da) Fremgangsmaade til ekstraktion af en fysiologisk aktiv substans fra fyrrekogler og anti-kontagioest laegemiddel fremstillet paa basis af denne substans
IT1223343B (it) Formulazioni farmaceutiche per somministrazione transdermica
JPS6447771A (en) Drug containing 2,4-diamino-5-(substituted benzyl)pyrimidinederivative and manufacture
NO180450C (no) Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin
IT8805224A0 (it) Composizione a base di poliesteri per la liberazione controllata di sostanze medicamentose.
GB8801863D0 (en) Pharmaceutical formulations with controlled drug release
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
ATA264087A (de) Pharmazeutische praeparate zur oralen verabreichung
ATE73662T1 (de) Diphosphonsaeurederivat enthaltendes arzneimittel zur oralen gabe.
DK152987D0 (da) Dosageform for nonimmediate release of one or more drugs
ITFI910264A1 (it) Procedimento per la produzione di un bollino farmaceutico od equivalente, e bollino cosi' realizzato
ATE76295T1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
ITBO920455A0 (it) Procedimento per preparare forme farmaceutiche a rilascio controllato ritardato del principio attivo e le forme farmaceutiche cosi' ottenu- te.
IT8719390A0 (it) Composizione farmaceutica per la prevenzione e il trattamento dell'aterosclerosi.
MX9203614A (es) Formulacion farmaceutica de liberacion controlada para administracion oral.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LES LABORATOIRES SERVIER, NEUILLY SUR SEINE, FR

R071 Expiry of right

Ref document number: 519820

Country of ref document: EP